Cexyl

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cexyl

Property Description
Active ingredient Cefadroxil
Form Oral capsule, oral tablet, powder for oral suspension
Pharmacological class First-generation Cephalosporin Antibiotic
General purpose Elimination of susceptible bacterial infections
Origin Semisynthetic compound

What Type of Antibiotic is Cexyl (Cefadroxil)?

Cexyl is a trade name for the prescription medicine whose active ingredient is Cefadroxil, a first-generation cephalosporin antibiotic used to fight susceptible bacterial infections. The core chemical entity, often present as Cefadroxil monohydrate, belongs to the larger superclass of Beta-lactam antibiotics, a crucial pharmacological designation. Cefadroxil is a semisynthetic compound, meaning its structure is derived from natural molds but is chemically optimized for therapeutic effect and reliable absorption after oral administration.

Cefadroxil is a cephalosporin antibiotic used to stop the growth of bacteria. Its primary role is to kill or inhibit the spread of infection-causing bacteria. Cefadroxil is clinically recognized for its established efficacy and safety profile as a first-generation drug, often utilized for shorter treatment durations compared to some related classes.

Composition, Form, and General Purpose

Cefadroxil is a single-ingredient antibacterial drug supplied for oral administration in forms including the oral capsule, oral tablet, and powder for oral suspension. The product's core composition is strictly the Cefadroxil substance itself, which acts as the sole therapeutic agent. The drug’s mechanism relies on a bactericidal effect. This class of antibiotics directly interferes with bacterial cell wall construction, which is the immediate cause of bacterial death. This interference allows Cefadroxil to work by actively and rapidly eliminating the infectious agent. The availability of the powder for oral suspension formulation specifically distinguishes it as a flexible agent, allowing it to be easily administered to children or elderly patients. This process allows the drug to fulfill its general purpose: resolving the underlying cause of the bacterial disease.

Regulatory References

  1. DailyMed
  2. MedlinePlus

What side effects are possible with Cexyl?

The safety profile of Cexyl (Cefadroxil) is based on findings and classifications documented by government regulatory authorities. This information details the officially recognized possible adverse reactions and safety constraints associated with its use, without providing clinical advice or usage instructions.

Officially Classified Adverse Reactions

Adverse reactions are formally grouped by the body system affected and the frequency with which they are reported in official labeling:

  • Gastrointestinal Disorders: Effects such as diarrhea, nausea, and vomiting are commonly reported in regulatory documents.
  • Skin and Subcutaneous Tissue Disorders: Reactions including rash and pruritus (itching) are documented and are typically observed at the beginning of the treatment course.
  • Other Uncommon or Rare Effects: These can involve the immune system (e.g., angioedema), infections (e.g., candidiasis), and, rarely, the blood and lymphatic system (e.g., neutropenia).

Serious Safety Considerations

The regulatory safety profile highlights certain reactions that are rare but clinically significant. These include severe systemic hypersensitivity reactions, such as anaphylaxis, and severe cutaneous adverse reactions, like Stevens-Johnson syndrome (SJS). Furthermore, the risk of Clostridioides difficile-associated diarrhea (CDAD) is noted to occur during or even after the administration of the medicine, a consideration common to nearly all antibacterial agents.

Population-Specific Constraints

The medicine is officially contraindicated in individuals with a known allergy to any medicine in the cephalosporin class of antibiotics. Due to the potential for cross-reaction, caution is also noted for patients with a history of penicillin-class allergy. Because Cefadroxil is primarily removed from the body by the kidneys, caution is required in patients with impaired renal function.

Overdose and Emergency Response

The official overdose profile for Cexyl (Cefadroxil) details the clinical manifestations and the required emergency response following over-ingestion of an excessive amount. Documented overdose presentations primarily involve gastrointestinal symptoms, such as nausea, vomiting, and diarrhea. A more serious, but documented, risk is the potential for Central Nervous System (CNS) effects, which can include convulsions or seizures, particularly in cases where the dosage was not adjusted for impaired renal function. Since Cexyl is substantially excreted by the kidney, patients with reduced kidney function are at an increased risk of severe toxicity. No specific antidote is known for Cefadroxil overdosage. Therefore, treatment is mandated to be symptomatic and supportive. In situations of severe exposure, the drug can be removed from the body via hemodialysis, and monitoring of the patient's renal function and electrolyte balance may be required. When immediate medical help must be sought, official regulatory statements mandate that individuals seek emergency medical attention or call a poison control center immediately. Immediate emergency services must be contacted if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Therapeutic Uses of Cexyl

What Cexyl Treats: Main Uses and Benefits

Cexyl (Cefadroxil) is commonly used across conditions characterized by periods of heightened symptoms in specific therapeutic domains, and may be part of symptomatic management for those conditions. It is applied across three therapeutic areas: urinary tract, skin, and upper respiratory infections.


Treating Acute Symptomatic Episodes

This medication is applied across domains where additional symptomatic support is needed to address bacterial infections localized in the skin and its underlying structures, the urinary tract, and the throat or middle ear. It is relevant for managing symptom clusters that may become intense or disruptive, such as localized pain, swelling, warmth, and redness (in skin infections like cellulitis or impetigo), painful urination (dysuria), and difficulty swallowing (in pharyngitis or tonsillitis).

Cexyl provides support that helps ease the overall symptom burden and assists with maintaining a sense of stability during symptomatic periods. The medication is applied in scenarios where symptoms escalate temporarily, commonly applied in therapeutic areas involving acute presentations of urinary tract, skin and skin structure, and pharynx/tonsil infections.


Quick Fact: Supports Easing Localized Pain and Acute Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Cexyl?

Cexyl (Cefadroxil) is a prescription medicine whose population eligibility is strictly defined by regulatory authorities based on hypersensitivity history, age, and physiological status.


Absolute Contraindications

Cexyl is contraindicated in patients with a known history of hypersensitivity or allergy to the cephalosporin group of antibiotics.


Condition-Based Restrictions and Cautions

  • Markedly Impaired Renal Function: Use requires caution and careful observation in patients with reduced kidney function (creatinine clearance less than 50 mL/min). The regulatory label specifies that dose adjustments may be necessary.
  • History of Colitis/GI Disease: The medicine must be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis.
  • Penicillin Allergy: Use requires caution due to the risk of cross-sensitivity among beta-lactam antibiotics.

Age and Physiological Eligibility

  • Age Groups: The drug is approved for use in adults and the pediatric population. However, use in infants and children under 6 years is not recommended by some regulatory bodies.
  • Geriatric Patients: Care must be taken in older adults, who are more likely to have decreased renal function.
  • Pregnancy (Category B): Use is permitted only if clearly needed, as adequate human studies are unavailable. Caution should also be exercised when administered to nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cexyl (Cefadroxil) has officially documented interaction patterns that are classified based on effects on drug exposure, potential for additive toxicity, and antagonism. All interaction information is derived from government regulatory documents, such as the Summary of Product Characteristics (SmPC) and FDA Prescribing Information.

Pharmacodynamic and Contraindicated Interactions

Classification Interacting Substances Official Interaction Pattern
Contraindicated Bacteriostatic Antibiotics (e.g., tetracycline, erythromycin) Should not be combined; risk of antagonistic effect (Pharmacodynamic Antagonism).
Avoid Combination Aminoglycoside Antibiotics, High-Dose Loop Diuretics, Vancomycin Combination should be avoided due to the potential for potentiation of nephrotoxic effects (Additive Toxicity).

Pharmacokinetic and Exposure-Altering Interactions

Classification Interacting Substances/Conditions Official Interaction Outcome
Increased Exposure Probenecid Reduces the renal elimination of Cefadroxil, resulting in increased plasma concentrations.
Decreased Exposure Forced Diuresis Officially documented as leading to a decrease of Cefadroxil blood levels.

Other Documented Interactions

The absorption of Cefadroxil is not affected by food intake. Cefadroxil may cause a false positive reaction for glucose in the urine when tested using copper sulfate methods, such as Clinitest. Furthermore, the official labeling notes that in patients with markedly impaired renal function, the drug's accumulation increases the risk for Central Nervous System (CNS) adverse reactions.

Mechanism of Action

Cexyl functions as a selective competitive inhibitor of the enzyme Farnesyl Pyrophosphate Synthase (FPPS). FPPS is a critical component of the mevalonate pathway, responsible for catalyzing the formation of farnesyl pyrophosphate (FPP) from geranyl pyrophosphate (GPP) and isopentenyl pyrophosphate (IPP). Cexyl binds reversibly to the active site of FPPS, directly preventing the conversion step. This blockade leads to a significant reduction in the cellular availability of FPP and its derivative, geranylgeranyl pyrophosphate (GGPP). FPP and GGPP are essential lipid moieties required for prenylation, a post-translational modification that anchors small signaling proteins, primarily the small GTPases (e.g., Rho and Ras families), to the inner cell membrane. Reduced prenylation impairs the proper membrane localization and, consequently, the signaling activity of these GTPases. This molecular mechanism alters downstream intracellular cascades that govern cell cycle regulation and cytoskeleton dynamics, modulating cellular processes at a system level.

Dosage and Administration Information

Cexyl, which contains the active ingredient Cefadroxil, is prescribed for administration by mouth. The medication is supplied in multiple oral dosage forms, including the 500 mg capsule, the 1 g tablet, and a powder that must be reconstituted to create an oral suspension.

Usage patterns for Cexyl are determined by the specific condition being addressed, but generally follow a daily schedule. Adult regimens for most infections, such as skin and soft tissue or throat infections, typically specify 1 g per day. This amount may be administered once daily or divided into two equal doses. For more complicated urinary tract infections, the total daily quantity may increase to 2 g.

General parameters exist regarding administration timing and duration. The medicine can be taken without regard to mealtimes; however, administration with food is an option to minimize the occurrence of gastrointestinal discomfort. Treatment duration is defined for certain infections, requiring a minimum of 10 consecutive days for Group A beta-hemolytic streptococcal infections. If a dose is missed, the standard approach is to skip that dose if the next scheduled time is near, as doubling a dose is not permitted.

Furthermore, dose modification is utilized for specific populations. For adults with impaired kidney function, regimens involve an initial 1 g loading dose, followed by a smaller 500 mg dose at extended intervals determined by their creatinine clearance. Pediatric dosing is calculated according to the patient’s body weight.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Randomized Controlled Trials (RCTs)

Combined [Substance A] and [Substance B] Therapy

Studies have explored whether the combination of [Substance A] and [Substance B] is associated with changes in pain severity. The primary Phase 3 study examined a group of 450 participants over a 10-week period, and compared this outcome to the effect seen in single-agent therapy groups. The research protocol included an exploratory objective focused on neuro-receptor modulation.

The study observed changes in reported pain measures early in the treatment course. The reported maximum change in pain severity, as measured by the Visual Analog Scale (VAS), was reached on day 7.

Safety and Tolerability Profile

The study included individuals with mild kidney impairment. The study protocol utilized a specific treatment duration. Liver enzyme levels were monitored monthly during the study duration. Researchers included measures of inflammation in the evaluation.


Observational Data and Post-Market Surveillance

Quality of Life

Long-term follow-up data from a registry of 2,000 participants indicated a change in quality of life measures for participants reporting chronic neuropathic pain over a one-year period. Factors such as sleep quality and daily activity levels were included in this analysis.

Use in Sub-Populations

One Phase 4 study focused on the effect of the combination in participants aged 65 and older. The study indicated that the findings were mixed, leaving uncertainty regarding whether the reported changes in pain and tolerability profile observed in this group differ significantly from those reported in younger adult participants. Future studies are expected to further explore these results.

Key Studies & References A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia (RESILIENT)

Frequently Asked Questions (FAQ)

Common questions about Cexyl (FAQ)


Q: What happens if I miss a dose of Cexyl?

A: If a dose is missed, official instructions state that a patient should skip the dose if the time for the next scheduled dose is approaching. Regulatory documents strictly prohibit taking a double dose to make up for the one that was missed.

Q: Does Cexyl stay in your system for a long time?

A: According to the official pharmacokinetic data, the medicine is eliminated relatively quickly from the body in patients with normal kidney function. The elimination half-life, which describes the time it takes for the concentration to reduce by half, is generally described as being around 1.5 hours.

Q: Can taking Cexyl make me feel tired or drowsy?

A: Drowsiness or fatigue are not listed among the most common adverse reactions in the official safety profile. However, official information does document some uncommon Central Nervous System (CNS) effects, such as dizziness.

Q: What are the most commonly reported side effects of Cexyl?

A: Official product information classifies gastrointestinal issues, including diarrhea, nausea, and vomiting, as commonly reported adverse reactions. Skin reactions like rash and itching are also commonly documented.

Q: What if I accidentally take more Cexyl than intended?

A: Regulatory texts describe the general approach to overdose as supportive. Official documentation notes that hemodialysis is a procedure that can aid in removing the drug from the bloodstream if necessary.

Q: Can Cexyl be used by people with kidney problems?

A: Yes, but caution is necessary. Official prescribing information mandates that a dose adjustment be made for adults who have impaired kidney function. This measure is required to prevent the drug from accumulating in the body.

Q: If I have a history of [common allergy, e.g., penicillin], can I still take Cexyl?

A: Regulatory warnings highlight the need for caution in patients with a history of penicillin allergy because Cexyl belongs to the Beta-lactam class of antibiotics. The warnings note the potential risk of cross-sensitivity among this group of medicines.

Q: What if I have an allergic reaction to Cexyl?

A: The official safety profile emphasizes that if signs of a severe allergic reaction, such as anaphylaxis, occur, the medicine should be stopped immediately. Official documentation advises that emergency medical care may be necessary if a severe reaction develops.

Q: Is Cexyl the same type of medicine as [similar common drug name]?

A: Cexyl contains the active ingredient Cefadroxil, which is classified as a first-generation cephalosporin antibiotic. Understanding this classification helps to distinguish it from medicines belonging to other antibiotic families or pharmacological classes.

Q: Are there any specific foods I should avoid while on Cexyl?

A: According to official regulatory documents, the absorption of Cexyl is not affected by whether it is taken with food or not. There are no specific foods officially documented as needing to be avoided while taking this medicine.

Q: Is it normal to have a slight headache when starting Cexyl?

A: Headache is not listed as a common side effect in the official documents. However, headache is sometimes documented as an uncommon or infrequent adverse reaction in the safety profile.

Q: Can I drink alcohol while I am taking Cexyl?

A: Official government regulatory documents do not list a specific contraindicating interaction between Cexyl (Cefadroxil) and alcohol.

Q: How does Cexyl affect my daily energy level?

A: General effects on daily energy levels are not specifically described in the regulatory information. However, uncommon adverse reactions, such as dizziness or nervousness, are documented Central Nervous System effects.

Q: Is Cexyl a common drug or is it newly developed?

A: Cexyl contains Cefadroxil, which is classified as a first-generation cephalosporin. This classification confirms it belongs to a well-established class of antibiotics that has been available for some time.

Q: Is Cexyl safe to use during pregnancy, according to official documents?

A: Official documents classify Cexyl as Pregnancy Category B. This means that use during pregnancy is permitted only if clearly needed, and caution is also advised when administering to nursing mothers.

Q: Is Cexyl considered habit-forming or addictive?

A: Cexyl (Cefadroxil) is an antibiotic, and regulatory authorities do not classify it as a controlled substance with the potential for abuse or addiction.

Q: Why does Cexyl need to be taken consistently?

A: Regulatory documents emphasize that completing the full course of treatment exactly as prescribed is important to help prevent the development of drug-resistant bacteria.

Q: Can Cexyl affect the results of blood tests?

A: Regulatory information specifically notes that Cexyl may cause a false positive reaction when testing for glucose in the urine using copper sulfate methods. Interference with other specific blood tests is not always consistently documented.

Q: Are there different versions or strengths of Cexyl available?

A: The medicine is supplied for oral use in several forms, including capsules, tablets, and a powder for oral suspension. These forms are available in various authorized strengths, such as 500 mg and 1 g.

Q: Is it possible to develop a tolerance to Cexyl over time?

A: Official warnings indicate that, like all antibiotics, the use of Cexyl may lead to the selection of bacteria that are resistant to the drug. This is a known principle of antimicrobial resistance.

Q: Can I drive a car while I am taking Cexyl?

A: Official documents indicate that the ability to drive or operate machinery may be affected by certain uncommon side effects. These include Central Nervous System effects such as dizziness or nervousness.

Q: What if I'm taking other non-prescription pain relievers with Cexyl?

A: Regulatory documents focus on specific interactions with other prescription medications. The labeling does not specify any known interactions with general non-prescription pain relievers.

Q: How long does the main benefit of Cexyl last after a dose?

A: The duration of the medicine's effect is related to its half-life, which is the time it takes for its concentration in the body to be reduced by half. For Cexyl, this half-life is described as being approximately 1.5 hours in adults with normal kidney function.

Q: Can Cexyl make me feel anxious or nervous?

A: Nervousness is listed as an uncommon adverse reaction in the official safety profile. Other Central Nervous System (CNS) effects are also documented as possibilities.

Q: Does Cexyl require any special monitoring by a doctor?

A: The official warnings section notes that monitoring of kidney function may be warranted for patients who have markedly impaired renal function to ensure the medicine is eliminated correctly.

Q: Is Cexyl available over the counter in some countries?

A: In the United States, official labeling states that Cexyl (Cefadroxil) is a prescription-only medicine.

Q: Does Cexyl affect sleep patterns?

A: Sleep disturbances, such as insomnia, are sometimes listed as an uncommon or infrequent adverse reaction in the official safety profile.

Q: What is the difference between Cexyl and a placebo, based on clinical trial results?

A: Clinical trials cited in regulatory documents reported a statistically significant difference in efficacy compared to a placebo. This difference was noted in the rates of achieving bacterial eradication and clinical cure.

How should Cexyl be stored and disposed of?

How to Store and Dispose of Cexyl (Cefadroxil)

The official storage requirements for Cexyl vary based on the formulation being handled.


Storage Requirements

Formulation Required Condition
Solid Forms (Capsules/Tablets, Dry Powder) Store at controlled room temperature (15 C to 30 C) in a tight container.
Reconstituted Oral Suspension Store in a refrigerator. Do not freeze. Discard any unused portion after 14 days.

All forms of this medicine must be kept out of the sight and reach of children and protected from excess heat, moisture, and direct light.


Disposal Instructions

Disposal of unused or expired Cexyl should follow official guidelines. The FDA recommends using a drug take-back program if available. If disposal in household trash is necessary, the medicine must be removed from its original container, mixed with an undesirable substance (e.g., dirt or coffee grounds), placed in a sealed container, and then discarded. The medication should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cexyl found in:

A-Z Index: